Search clinical trials for: dacomitinib fed

Total 2567 results

Pfizer

Completed

Evaluation Of The Potential Effect That The Administration Of Food Or Antacid Medication May Have In The Oral Absorption Of Dacomitinib (PF-00299804)

Healthy Volunteers

Belgium
Shanghai Chest Hospital

Recruiting

First-line Treatment With Dacomitinib Plus Anlotinib for Patients With Advanced NSCLC With EGFR 21L858R Mutations

Non-Small Cell Lung Cancer (NSCLC)

China
Peking Union Medical College

Recruiting

Dacomitinib Treatment Followed by 3rd Generation EGFR-TKI in Patients With EGFR Mutation Positive Advanced NSCLC

NSCLC Stage IV | EGFR Activating Mutation | NSCLC Stage IIIB | NSCLC, Recurrent

China
Shanghai Chest Hospital

Recruiting

Dacomitinib in Lung Cancer With Uncommon EGFR Mutations

Non-small Cell Lung Cancer Metastatic | EGF-R Positive Non-Small Cell Lung Cancer

China
Guangdong Association of Clinical Trials

Not yet recruiting

An Open Label, Multicenter, Phase II Study of Dacomitinib for EGFR Mutated Non-Small Cell Lung Cancer (NSCLC) With Brain Metastases

Dacomitinib for EGFR Mutated Non-Small Cell Lung Cancer (NSCLC) With Brain Metastases
David Piccioni, M.D., Ph.D
Pfizer

Terminated

A Phase II Study of Dacomitinib in Progressive Brain Metastases

Brain Cancer

United States
Pfizer

Completed

A Rollover Protocol of Dacomitinib For Patients In Japan

NSCLC

Japan
Pfizer

Recruiting

Real World Utilization and Outcomes With Dacomitinib First Line Treatment for EGFR Mutation-positive Advanced Non Small Cell Lung Cancer Among Asian Patients - A Multi Center Chart Review

Lung Cancer

Malaysia
Pfizer

Completed

Dacomitinib (PF-00299804) Pharmacokinetics In Chinese Healthy Volunteers

Healthy

China
Pfizer

Completed

A Study To Compare Pharmacokinetics Of Dacomitinib (PF-00299804) Between Healthy Subjects And Subjects With Mild And Moderate Hepatic Impairment

Healthy | Otherwise Healthy Volunteers With Mild or Moderate Hepatic Dysfunction

United States
Pfizer

Completed

A Study To Assess Absorption Of Study Drug Dacomitinib (PF-00299804), Given As An Oral Tablet Compared To An Intravenous Infusion In Healthy Volunteers

Healthy Volunteers

United Kingdom
United States Army Research Institute of Environmental...
US Army Research and Development Command- Soldier Center

Completed

Effects of Energy and Physical Density Manipulation on Appetite

Eating Behavior | Appetite

United States
Pfizer

Recruiting

Special Investigation for VIZIMPRO Tablets (Secondary Data Collection Study; Safety and Efficacy of VIZIMPRO Under Japanese Medical Practice)

EGFR Mutation-positive Inoperable or Reccrent NSCLC

Japan
Grupo Español de Investigación en Neurooncología
Pfizer

Completed

Safety and Efficacy of PF-299804 (Dacomitinib), a Pan-HER Irreversible Inhibitor, in Patients With Recurrent Glioblastoma With EGFR Amplification or Presence of EGFRvIII Mutation. A Phase II CT.

Glioblastoma | Brain Tumor, Recurrent

Spain
Fondazione IRCCS Istituto Nazionale dei Tumori,...
Pfizer

Completed

Dacomitinib (PF-00299804) in Advanced/Metastatic Squamous Cell Carcinoma of the Penis (HER-Uro01)

Carcinoma, Squamous Cell | Penile Neoplasms

Italy
Pfizer

Completed

Dacomitinib (PF-00299804) As A Single Oral Agent In Selected Patients With Adenocarcinoma Of The Lung

Carcinoma, Non-small Cell

United States, Taiwan, Korea, Republic of, Japan, Hong Kong
Fondazione IRCCS Istituto Nazionale dei Tumori,...

Unknown

Efficacy and Safety of Dacomitinib in the Treatment of Skin Squamous Cell Cancer

Skin Squamous Cell Cancer

Italy
LED Intellectual Properties, LLC

Unknown

A Controlled Study to Investigate the Effect of Multi-wave Light Emitting Diode (LED) Bed on Blood Pressure and Endothelial Function

Hypertension

United States
Pfizer

Completed

Evaluate Severe Hepatic Impairment on Dacomitinib PK

Severe Hepatic Impairment

United States
Pfizer

Completed

A Study Of Dacomitinib (PF-00299804) In Patients With Advanced Non-Small Cell Lung Cancer

Non-small Cell Lung Cancer

Korea, Republic of, United States
Wake Forest University Health Sciences

Recruiting

A Pilot Study of Revian Red All LED Cap as a Novel Treatment for Central Centrifugal Cicatricial Alopecia

Central Centrifugal Cicatricial Alopecia

United States
Kaohsiung Medical University

Completed

Develop Novel Phototherapy for Health Care of Patients With Sleep Disorder, Mild Cognitive Impairment, or Dementia

Sleep Disorder | Dementia | Mild Cognitive Impairment | Phototherapy

Taiwan
National Cancer Centre, Singapore
Singapore Translational Cancer Consortium; Genome Institute of Singapore; Cancer...

Recruiting

Phase-2 Dacomitinib Study on Patients With EGFR-Driven Advanced Solid Tumours With Low EGFR-AS1 IncRNA Expr or Other Novel Emerging Biomarkers

Non-small Cell Lung Cancer | Head and Neck Squamous Cell Carcinoma | Advanced Solid Tumours

Singapore
Wake Forest University Health Sciences

Recruiting

A Study of Revian Red All LED Cap as a Novel Treatment for Central Centrifugal Cicatricial Alopecia

Central Centrifugal Cicatricial Alopecia

United States
Fayoum University Hospital

Completed

The Ratio Of Femoral Vein Diameter To Femoral Artery Diameter With Pulse Pressure Variation As A Diagnostic Tool

Mechanically Ventilated Patients

Egypt
Samsung Medical Center

Recruiting

Central Nervous System(CNS) Efficacy of Dacomitinib

Non Small Cell Lung Cancer | Brain Metastases

Korea, Republic of
Yonsei University

Recruiting

The Effect of Robotics-assisted Tilt Table and Functional Electrical Stimulation in Stroke Patients

Stroke

Korea, Republic of
National Cancer Centre, Singapore
Pfizer

Active, not recruiting

Phase 2 Study of Dacomitinib in NSCLC

NSCLC Stage IV | NSCLC Stage IIIB | Recurrent NSCLC | NSCLC Stage IIIC | EGFR Positive Non-Small Cell Lung Cancer

Korea, Republic of, Hong Kong, Thailand, Singapore, Malaysia
Pfizer

Completed

ARCHER1050: A Study of Dacomitinib vs. Gefitinib in 1st-Line Treatment Of Advanced NSCLC.

Non-small Cell Lung Cancer With EGFR-Activating Mutations

Italy, Poland, China, Hong Kong, Spain, Korea, Republic of, Japan
Pfizer

Not yet recruiting

A Study to Learn About Dacomitnib in Patients With Non-small Cell Lung Cancer Which Has Spread to the Brain.

Carcinoma, Non-Small-Cell Lung
Hermano Miguel Foundation

Completed

Study of LED Phototherapy for Musculoligamentous Lesions

Sprains and Strains | Tendinopathy | Fasciitis | Epicondylitis | Muscle Spasm

Ecuador
Manamed Inc.

Unknown

Effects of Red Light LED Therapy on Body Contouring

Obesity

United States
Afeka, The Tel-Aviv Academic College of Engineering
Hebrew University of Jerusalem

Completed

Evaluation of Peripheral Microcirculation Hemodynamics Following Various Changes Based on Noninvasive Thermography (MRT02)

Microcirculation

Israel
Afeka, The Tel-Aviv Academic College of Engineering
Sheba Medical Center

Completed

Evaluating the State of Microvessels by Minimum Rise Time (MRT01) (MRT01)

Healthy

Israel
Biofrontera Bioscience GmbH

Recruiting

Study to Evaluate the Safety, Tolerability and Efficacy of BF-200 ALA (Ameluz®) in the Field-directed Treatment of Actinic Keratosis (AK) on the Extremities and Neck/Trunk With Photodynamic Therapy (PDT) Using a RhodoLED Lamp

Actinic Keratoses

United States
Montana State University
Organic Advisory and Education Council

Completed

Impact of Beef on Metabolites and Inflammation

Healthy

United States
University of Bergen
Glamox

Completed

Light Intervention for Adaptation to Night Work

Sleep | Sleep Deprivation | Shift-Work Related Sleep Disturbance

Norway
University of Colorado, Denver
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Not yet recruiting

Time and Nutrient-Dependent Effects of Aerobic Exercise on Metabolism in Adults (TANDEM Study) (TANDEM)

Healthy | Overweight and Obesity

United States
University of Ulster
University College Dublin; University College Cork

Completed

Effect of Consuming Pork From Seaweed Extract Fed Animals on Antioxidant Status

Antioxidant Status, Inflammation

United Kingdom
University of Nove de Julho

Completed

Effects of Photobiomodulation Conditioning in Impacted Third Molars

Impacted Third Molar Tooth

Brazil
University Health Network, Toronto

Completed

Dacomitinib Plus Radiotherapy, With and Without Cisplatin in Patients With Squamous Cell Carcinoma of the Head and Neck

Squamous Cell Carcinoma of the Head and Neck

Canada
Nottingham Trent University
Loughborough University

Completed

Fasted Evening Exercise: Performance and Compensatory Eating

Obesity

United Kingdom
Utah State University
Duke University; United States Department of Agriculture (USDA)

Recruiting

Beef and Plant Burger Metabolomics Study

Inflammatory Response

United States
Hanmi Pharmaceutical Company Limited

Completed

Single-dose, 2-way Crossover Open Study to Evaluate the Food Effect on the PK of HCP1201 in Healthy Volunteers

Diabetes Mellitus

Korea, Republic of
University of Colorado, Denver

Completed

Evaluating Color Perception Under LED Red/Green and Green Dominant Light

Color Blindness, Acquired

United States
University of British Columbia
University of Otago

Not yet recruiting

Brain Substrate Switch to Ketones and Lactate (BSS)

Metabolic Diseases | Aging Problems

Canada
State University of New York at Buffalo
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Completed

Study of Nutrition and Activity in Kids (SNAK)

Obesity, Adolescent | Adolescent Behavior
Medical College of Wisconsin

Terminated

Near-infrared Light-emitting Diode (NIR-LED) Therapy for Leber's Hereditary Optic Neuropathy (LHON) (LHON)

Leber's Hereditary Optic Neuropathy (LHON)

United States
Heinz Italia SpA

Recruiting

Potential Protective Effect of a Formula Supplemented With Fermented Matrices on the Risk of Developing Neonatal Sepsis

Neonatal Sepsis

Italy
University of Toronto

Completed

Bodyweight Interval Exercise in the Fed Versus Fasted State (BWE)

Exercise

Canada

Search clinical trials for: dacomitinib fed

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Kuwait

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations